Mitochondrial cristae architecture protects against mtDNA release and inflammation

Area of Science:

• Mitochondrial biology
• Immunology
• Aging research

Background:

• Mitochondrial damage and subsequent release of mitochondrial DNA (mtDNA) activate the type I interferon (IFN-I) response through the cGAS-STING pathway.
• mtDNA-induced inflammation is implicated in autoimmune and age-related degenerative disorders.
• The specific mitochondrial structures and mechanisms that lead to inflammation remain largely unknown.

Purpose of the Study:

• To identify regulators of the IFN-I response by performing a mitochondria-targeted CRISPR knockout screen.
• To elucidate the role of mitochondrial cristae architecture in preventing mtDNA release and subsequent inflammation.

Main Methods:

• Conducted a mitochondria-targeted CRISPR knockout screen to identify regulators of the type I interferon (IFN-I) response.
• Investigated the impact of disrupting cristae architecture components on mtDNA release and IFN-I signaling.
• Utilized mouse models to study the in vivo effects of specific genetic disruptions, such as MTX2 knockout.

Main Results:

• The screen identified numerous regulators of cristae architecture, including cardiolipin, OPA1, MICOS, SAM, MIB, PHB, and F1F0-ATP synthase.
• Disruption of these cristae organizers consistently led to mtDNA release and activation of the STING-dependent IFN-I response.
• Knocking out MTX2, a SAM complex subunit, induced a significant STING-dependent IFN-I response in mouse liver, linking it to progeria.

Conclusions:

• Mitochondrial cristae architecture plays a critical role in preventing the release of mtDNA and subsequent inflammation.
• Mitochondrial cristae disorganization is mechanistically linked to inflammation, identifying it as a key factor in aging and related diseases.
• These findings provide novel insights into the interplay between mitochondrial structure, innate immunity, and the aging process.